Performance of commercially available SmartWatch-based electrocardiography to identify atrial fibrillation during exercise testing: the WATCH-ECG study

Recruiting

• Conditions: Afib; irregular heart rhythm; 10007521

• Registration Number: NL-OMON50030
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 70

Inclusion Criteria

- 18 years of age or older;
- Willing and able to provide written informed consent;
- Scheduled for routine exercise testing, irrespective of indication;
- Willing to undergo an additional ECG recording using the Apple Watch.

Exclusion Criteria

- Unwilling or unable to provide written informed consent;
- Fall-prone patients during exercise testing, e.g. due to limited mobility,
visual or cognitive impairment.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Main study endpoint<br /><br>This study is designed to assess diagnostic accuracy, as defined by sensitivity<br /><br>and specificity, of a commercially available heart rate monitor (Apple Watch)<br /><br>in detecting AF during tachycardia. Details of the device are provided in this<br /><br>chapter.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>None.</p><br>